Search - tctmd.com

Displaying 41 - 60 of 174

Sort: Relevancy | Date

Presentation TCT 2025

TCT 650: Target-Trial Emulation of Physiology-Guided PCI and Its Impact in Patients with Heart-Failure with Reduced Ejection Fraction

Presenter: Firas Anaya

October 26, 2025

Presentation TCT 2025

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

Presenter: Tuomas T. Rissanen

October 26, 2025

Presentation TCT 2025

TCT 1808: Novel Mechanical Circulatory Device for High-Risk PCI and Aortic Balloon Valvuloplasty in Patient With Low Ejection Fraction & Severe Aortic Stenosis

Presenter: Tomasz Pawlowski

October 25, 2025

Presentation TCT 2025

TCT 1803: Complete Revascularization in Patients With Two Chronic Total Occlusions and Low Ejection Fraction Supported With a Percutaneous Ventricular Assist Device

Presenter: Jiancheng Xiu

October 25, 2025

Presentation ESC 2025

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Presenter: Faiez Zannad

August 30, 2025

Presentation ESC 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Presenter: Borja Ibanez

August 30, 2025

Presentation NY Valves 2025

Successful TAVR in a Patient Wth Large Apical LV Thrombus and Poor Ejection Fraction

Presenter: Vivek Patel

June 26, 2025

Presentation NY Valves 2025

Left Ventricle Ejection Fraction Deterioration After TAVI: Managing Paravalvular Leak

Presenter: Mercedes Quiroga

June 26, 2025

Presentation NY Valves 2025

Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial

Presenter: Yukari Kobayashi

June 26, 2025

Presentation NY Valves 2025

Treatment Implications of Tricuspid Regurgitation in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Mitsunobu Kitamura

June 26, 2025

Presentation NY Valves 2025

Automated CT-Derived Annular Displacement Predicts Early RV Strain Changes Independently of Baseline Right Ventricular Ejection Fraction After Transcatheter Tricuspid Valve Replacement

Presenter: Max Potratz

June 25, 2025

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation THT 2025

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Presenter: Thitiphan Srikulmontri

February 12, 2025

Presentation THT 2025

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Presenter: Thitiphan Srikulmontri

February 12, 2025

Presentation THT 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presenter: Thitiphan Srikulmontri

February 12, 2025

Presentation THT 2025

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Presenter: Qianlan Xi

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Pressure-Volume Loop Derived Left Ventricular Hypercontractility Is Associated With Reduced Long-Term Survival in Heart Failure With Preserved Ejection Fraction

Presenter: Sebastian Roschx

February 12, 2025

Presentation THT 2025

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 12, 2025

Advertisement

TCT 650: Target-Trial Emulation of Physiology-Guided PCI and Its Impact in Patients with Heart-Failure with Reduced Ejection Fraction

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

TCT 1808: Novel Mechanical Circulatory Device for High-Risk PCI and Aortic Balloon Valvuloplasty in Patient With Low Ejection Fraction & Severe Aortic Stenosis

TCT 1803: Complete Revascularization in Patients With Two Chronic Total Occlusions and Low Ejection Fraction Supported With a Percutaneous Ventricular Assist Device

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Successful TAVR in a Patient Wth Large Apical LV Thrombus and Poor Ejection Fraction

Left Ventricle Ejection Fraction Deterioration After TAVI: Managing Paravalvular Leak

Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial

Treatment Implications of Tricuspid Regurgitation in Patients With Heart Failure With Reduced Ejection Fraction

Automated CT-Derived Annular Displacement Predicts Early RV Strain Changes Independently of Baseline Right Ventricular Ejection Fraction After Transcatheter Tricuspid Valve Replacement

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Pressure-Volume Loop Derived Left Ventricular Hypercontractility Is Associated With Reduced Long-Term Survival in Heart Failure With Preserved Ejection Fraction

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content